Meissa Vaccines competitorsClear all

Meissa Vaccines's top competitors include Edgewise Therapeutics, Allakos, CinCor Pharma and Polyneuron.
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background
Meissa Vaccines
Meissa Vaccines
Meissa Vaccines is a pharmaceutical company focused on the advancement of unmet vaccines against viruses that cause serious human diseases, such as a respiratory syncytial virus.
Edgewise Therapeutics
Edgewise Therapeutics
Edgewise Therapeutics is a biotechnology company focused on developing therapies for muscle disorders.
Allakos
Allakos
Allakos, a biopharmaceutical company, focuses on developing therapeutic antibodies targeting allergic, inflammatory, and proliferative diseases.
CinCor Pharma
CinCor Pharma
CinCor is a clinical-stage biopharmaceutical company targeting cardiovascular, metabolic and kidney diseases.
Polyneuron
Polyneuron
Polyneuron is a pharmaceutical company that is committed to the development of a new drug class for the treatment of autoimmune disorders.
Founding Date
Founding Date
2014
Founding Date
2017
Founding Date
2012
Founding Date
2018
Founding Date
2014
Type
Type
Private
Type
Public
Type
Public
Type
Private
Type
Private
Tags
Locations
Locations
South San Francisco, US HQ
Redwood City, US
Locations
Boulder, US HQ
Locations
Redwood City, US HQ
Locations
Cincinnati, US HQ
Locations
Basel, CH HQ
Employees
Employees
235% increase
Employees
19
Employees
967% increase
Employees
433% increase
Employees
176% increase
Valuation ($)
Valuation ($)
N/A
Valuation ($)
1 b
Valuation ($)
4.4 b
Valuation ($)
N/A
Valuation ($)
N/A
Twitter followers
Twitter followers
153
Twitter followers
N/A
Twitter followers
N/A
Twitter followers
N/A
Twitter followers
254
Alexa Website Rank
Alexa Website Rank
192379
Alexa Website Rank
N/A
Alexa Website Rank
259917
Alexa Website Rank
N/A
Alexa Website Rank
407864

Financial

Net income
Net income
N/A
Net income
($17.1m) (FY, 2020)
Net income
($153.5m) (FY, 2020)
Net income
N/A
Net income
N/A

Funding

Latest funding round
Latest funding round
$ 30m (almost 2 years ago)
Latest funding round
N/A
Latest funding round
N/A
Latest funding round
$ 50m (about 2 years ago)
Latest funding round
$ 15.3m (10 months ago)
Total funding raised
Total funding raised
$ 33.4m
Total funding raised
$ 50m
Total funding raised
N/A
Total funding raised
$ 50m
Total funding raised
$ 44.3m
For sources of this data, please see the company profile

View company profiles

Edgewise Therapeutics
HQ
Boulder, US
Employees
19

Edgewise Therapeutics is a biotechnology company focused on developing therapies for muscle disorders.

View company
Allakos
HQ
Redwood City, US
Employees
96↑ 7% increase

Allakos, a biopharmaceutical company, focuses on developing therapeutic antibodies targeting allergic, inflammatory, and proliferative diseases.

View company
CinCor Pharma
HQ
Cincinnati, US
Employees
4↑ 33% increase

CinCor is a clinical-stage biopharmaceutical company targeting cardiovascular, metabolic and kidney diseases.

View company
Polyneuron
HQ
Basel, CH
Employees
17↑ 6% increase

Polyneuron is a pharmaceutical company that is committed to the development of a new drug class for the treatment of autoimmune disorders.

View company